Safety and efficacy evaluation of personalized exercise prescription during chemotherapy for lung cancer patients

Qian Li,Chen Guo,Baoshan Cao,Fanjie Zhou,Jiulong Wang,Hong Ren,Yanchun Li,Mopei Wang,Yane Liu,Hua Zhang,Liwen Ma
DOI: https://doi.org/10.1111/1759-7714.15272
IF: 3.223
2024-03-12
Thoracic Cancer
Abstract:Compared to control group in lung cancer patients, the exercise group which followed individualized exercise prescriptions showed improvements not only in physical fitness indicators such as 6MWT, VO2peak, muscle content, grip strength, but also in clinical indicators such as lung capacity, D‐dimer, CRP, uric acid, triglycerides, hemoglobin, and quality of life after 12 weeks. Background To explore the safety and effectiveness of personalized exercise intervention during chemotherapy for lung cancer patients who were relatively weak and with compromised cardiopulmonary function. Methods Thirty‐eight lung cancer patients treated with chemotherapy at Peking University Third Hospital were enrolled in this prospective study. The exercise group (N = 21) received individualized exercise guidance based on personal test results and exercised regularly, while the control group (N = 17) only received exercise education and planed exercise methods according to their own preferences. Both groups underwent three fitness tests and clinical indicator assessments at 0, 6, and 12 weeks after starting the exercise, and the differences in trends of various indicators between the two groups were compared. Results No exercise‐related adverse events occurred during the 12‐week exercise period. After 12 weeks of exercise training, in terms of fitness, the exercise group showed significant improvements in 6‐min walk test (6MWT) (p
oncology,respiratory system
What problem does this paper attempt to address?